Agile Therapeutics Management
Management criteria checks 4/4
Agile Therapeutics' CEO is Al Altomari, appointed in Oct 2010, has a tenure of 13.58 years. total yearly compensation is $788.72K, comprised of 76.1% salary and 23.9% bonuses, including company stock and options. directly owns 0.019% of the company’s shares, worth $493.91. The average tenure of the management team and the board of directors is 3 years and 5.9 years respectively.
Key information
Al Altomari
Chief executive officer
US$788.7k
Total compensation
| CEO salary percentage | 76.1% |
| CEO tenure | 13.6yrs |
| CEO ownership | 0.02% |
| Management average tenure | 3yrs |
| Board average tenure | 5.9yrs |
Recent management updates
Recent updates
Agile appoints chief commercial officer from within ranks amid leadership revamp
Oct 10Agile gains as H.C. Wainwright sees 630% upside potential
Jul 11Agile Therapeutics prices $24M upsized stock offering
Jul 01Agile Therapeutics: Twirla's Lackluster Launch Forces Me To Change My Strategy
Apr 04Agile Therapeutics: Bullish On Capitulation And Max Pain
Oct 19Agile Therapeutics: Another Quarter Of Progress And Another Opportunity To Buy
Jul 30Agile Therapeutics, Inc. 2021 Q1 - Results - Earnings Call Presentation
May 06How Many Agile Therapeutics, Inc. (NASDAQ:AGRX) Shares Did Insiders Buy, In The Last Year?
Feb 25
Agile Therapeutics issues cash projection at JP Morgan healthcare conference
Jan 14Assessing Agile Therapeutics
Jan 10How Many Agile Therapeutics, Inc. (NASDAQ:AGRX) Shares Do Institutions Own?
Jan 04Agile Therapeutics announces peer-reviewed publication of late-stage study for Twirla contraception patch
Nov 30Agile Therapeutics EPS in-line
Nov 12CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$789k | US$601k | -US$14m |
| Sep 30 2023 | n/a | n/a | -US$14m |
| Jun 30 2023 | n/a | n/a | -US$19m |
| Mar 31 2023 | n/a | n/a | -US$20m |
| Dec 31 2022 | US$841k | US$601k | -US$25m |
| Sep 30 2022 | n/a | n/a | -US$41m |
| Jun 30 2022 | n/a | n/a | -US$52m |
| Mar 31 2022 | n/a | n/a | -US$64m |
| Dec 31 2021 | US$2m | US$594k | -US$71m |
| Sep 30 2021 | n/a | n/a | -US$69m |
| Jun 30 2021 | n/a | n/a | -US$68m |
| Mar 31 2021 | n/a | n/a | -US$61m |
| Dec 31 2020 | US$2m | US$555k | -US$52m |
| Sep 30 2020 | n/a | n/a | -US$40m |
| Jun 30 2020 | n/a | n/a | -US$29m |
| Mar 31 2020 | n/a | n/a | -US$22m |
| Dec 31 2019 | US$1m | US$507k | -US$19m |
| Sep 30 2019 | n/a | n/a | -US$16m |
| Jun 30 2019 | n/a | n/a | -US$16m |
| Mar 31 2019 | n/a | n/a | -US$18m |
| Dec 31 2018 | US$2m | US$494k | -US$20m |
| Sep 30 2018 | n/a | n/a | -US$22m |
| Jun 30 2018 | n/a | n/a | -US$26m |
| Mar 31 2018 | n/a | n/a | -US$28m |
| Dec 31 2017 | US$1m | US$492k | -US$28m |
Compensation vs Market: Al's total compensation ($USD788.72K) is about average for companies of similar size in the US market ($USD667.96K).
Compensation vs Earnings: Al's compensation has been consistent with company performance over the past year.
CEO
Al Altomari (64 yo)
13.6yrs
Tenure
US$788,718
Compensation
Mr. Alfred F. Altomari, also known as Al, had been an Independent Chairman of the Board of Baudax Bio Inc. since November 2019 until May 04, 2022. He has been the Chief Executive Officer at Agile Therapeut...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 13.6yrs | US$788.72k | 0.019% $ 493.9 | |
| CFO, Senior VP & Treasurer | less than a year | US$478.91k | 0.0012% $ 30.8 | |
| Senior VP & Chief Administrative Officer | 1.5yrs | US$554.69k | 0.00044% $ 11.6 | |
| Senior VP & Chief Medical Officer | 3.8yrs | US$537.78k | 0% $ 0 | |
| Senior VP and Chief Corporate Planning & Supply Chain Officer | 6.6yrs | US$557.49k | 0.00042% $ 11.1 | |
| Senior VP & Chief Commercial Officer | 2.3yrs | no data | no data |
3.0yrs
Average Tenure
57yo
Average Age
Experienced Management: AGRX's management team is considered experienced (3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 20.3yrs | US$788.72k | 0.019% $ 493.9 | |
| Independent Director | 9.5yrs | US$71.69k | 0.00058% $ 15.3 | |
| Lead Independent Director | 7.8yrs | US$101.69k | 0.00058% $ 15.3 | |
| Independent Director | 3.9yrs | US$61.69k | 0.00055% $ 14.5 | |
| Director | 2.6yrs | US$61.69k | 0.00057% $ 15.0 | |
| Independent Director | 3.9yrs | US$84.19k | 0.00055% $ 14.5 |
5.9yrs
Average Tenure
67yo
Average Age
Experienced Board: AGRX's board of directors are considered experienced (5.9 years average tenure).